Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 4, 2005, Pages 821-825

  Lee, Kyoung Mu ^a   Choi, Ji Yeob ^a   Sue, Kyung Park ^c   Chung, Hye Won ^d   Ahn, Byungchan ^e   Yoo, Keun Young ^a   Han, Wonshik ^a   Noh, Dong Young ^a   Ahn, Sei Hyun ^b   Kim, Ho ^a   Wei, Qingyi ^f   Kang, Daehee ^a  

^a Seoul National University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Konkuk University   (South Korea)

^d Ewha Womans University School of Medicine   (South Korea)

^e University of Ulsan   (South Korea)

^f UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ATM PROTEIN; NUCLEASE;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; ATAXIA TELANGIECTASIA; BAYES THEOREM; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIPLOIDY; EDUCATION; ENZYME ASSAY; FAMILY HISTORY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGIC SKIN REACTION; HUMAN; KOREA; MAJOR CLINICAL STUDY; PARITY; PREGNANCY; PREMENOPAUSE; PRIORITY JOURNAL; SMOKING;

BAYES THEOREM; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; FEMALE; HAPLOTYPES; HUMANS; KOREA; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN-SERINE-THREONINE KINASES; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 20144387375     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-04-0330     Document Type: Article

References (20)

1. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995;268:1749-53.
2. Lavin MF, Concannon P, Gatti RA. Eighth international workshop on ataxia-telangiectasia (ATW8). Cancer Res 1999;59:3845-9.
3. Shiloh Y. ATM (ataxia telangiectasia mutated): expanding roles in the DNA damage response and cellular homeostasis. Biochem Soc 2001;29:661-6.
4. Meyn MS. Ataxia-telangiectasia and cellular response to DNA damage. Cancer Res 1995;55:5991-6000.
5. Swift M, Reitnauer PJ, Morrell D, Chase CL. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 1987;21:1289-94.
6. Easton DF. Cancer risks in A-T heterozygotes. Int J Radiat Biol 1994;66:S177-82.
7. Athma P, Rappaport R, Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 1996;92:130-4.
8. Inskip HM, Kinlen LJ, Taylor AMR, Woods CG, Arlett CF. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia. Br J Cancer 1999;79:1304-7.
9. Olsen JH, Hahnemann JM, Borresen-Dale AL, et al. Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries. J Natl Cancer Inst 2001;93:121-7.
10. Geoffroy-Perez B, Janin M, Ossian K, et al. Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer 2001;93:288-93.
11. FitzGerald MG, Bean JM, Hedge SR, et al. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 1997;15:307-10.
12. Broeks A, Urbanus JHM, Floore AN, et al. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet 2000;66:494-500.
13. Dörk T, Bendix R, Bremer M, et al. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res 2001;61:7608-15.
14. Bretsky P, Haiman CA, Gilad S, et al. The relationship between twenty missense ATM variants and breast cancer risk: The multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2003;12:733-8.
15. Angele S, Romestaing P, Moullan N, et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 2003;63:8717-25.
16. Sommer SS, Jiang Z, Feng J, et al. ATM missense mutations are frequent in patients with breast cancer. Cancer Genet Cytogenet 2003;145:115-20.
17. Spurdle AB, Hopper JL, Chen X, et al. No evidence for association of ataxiatelangiectasia mutated gene T2199C and C3161G amino acid substitution variants with risk of breast cancer. Breast Cancer Res 2002;4:R15 doi:10.1186/bcr534.
18. Bonnen PE, Story MD, Ashorn CL, Buchholz TA, Weil MM, Nelson DL. Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium. Am J Hum Genet 2000;67:1437-51.
19. Thorstenson YR, Shen P, Tusher VG, et al. Global analysis of ATM polymorphism reveals significant functional constraints. Am J Hum Genet 2001;69:396-412.
20. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003;73:1162-9.